(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -87.36%5.53M | -67.55%61.37M | -58.22%43.79M | -65.90%189.11M | -58.83%104.83M | -39.10%554.51M | 59.23%254.64M | -40.99%910.56M | -78.53%159.92M | -15.72%1.54B |
Operating income | -87.36%5.53M | -67.55%61.37M | -58.22%43.79M | -65.90%189.11M | -58.83%104.83M | -39.10%554.51M | 59.23%254.64M | -40.99%910.56M | -78.53%159.92M | -15.72%1.54B |
Cost of sales | 85.22%-5.45M | 66.95%-53.28M | 54.27%-36.84M | 66.57%-161.22M | ---80.55M | ---482.22M | ---- | ---- | ---- | ---- |
Operating expenses | 85.22%-5.45M | 66.95%-53.28M | 54.27%-36.84M | 66.57%-161.22M | 61.83%-80.55M | 36.44%-482.22M | -63.81%-211.06M | 41.49%-758.69M | 80.26%-128.85M | 17.82%-1.3B |
Gross profit | -98.72%89K | -71.02%8.09M | -71.34%6.96M | -61.41%27.9M | -44.29%24.28M | -52.40%72.29M | 40.25%43.57M | -38.37%151.88M | -66.28%31.07M | -2.62%246.43M |
Selling expenses | 54.33%-390K | 23.09%-1.9M | 40.69%-854K | 73.61%-2.46M | 61.66%-1.44M | 27.23%-9.34M | 23.81%-3.76M | -24.92%-12.83M | -16.74%-4.93M | 11.64%-10.27M |
Administrative expenses | 20.63%-5.42M | 50.42%-21.84M | 53.14%-6.83M | 33.42%-44.05M | -7.08%-14.57M | -80.91%-66.17M | 6.53%-13.6M | 6.85%-36.57M | 22.20%-14.55M | 4.29%-39.26M |
Research and development expenses | ---- | ---- | ---- | ---- | ---- | ---- | -85.35%-9.54M | 27.51%-46.03M | ---5.15M | ---63.5M |
Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | 18,391.70%860.3K | ---- | ---4.7K | --1.5M |
Impairment and provision | -70.29%11.7M | 102.09%18.77M | 147.08%39.37M | -108.30%-899.18M | -31,611.33%-83.63M | -0.08%-431.68M | 99.19%-263.71K | -612.49%-431.33M | -342.15%-32.42M | -200.80%-60.54M |
-Other impairment is provision | -70.29%11.7M | 102.09%18.77M | 147.08%39.37M | -108.30%-899.18M | -31,611.33%-83.63M | -0.08%-431.68M | 99.19%-263.71K | -612.49%-431.33M | -342.15%-32.42M | -200.80%-60.54M |
Special items of operating profit | -94.70%2.03M | 131.60%11.94M | 570.71%38.23M | -61.55%-37.78M | -1,432.97%-8.12M | -538.44%-23.38M | -87.17%609.32K | -8.90%5.33M | -17.20%4.75M | -9.76%5.85M |
Adjustment items of operating profit | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | -89.59%8M | 101.58%15.05M | 192.10%76.88M | -108.51%-955.58M | -596.12%-83.48M | -22.81%-458.28M | 171.76%16.83M | -589.05%-373.18M | -134.67%-23.45M | -59.14%76.31M |
Financing income | -54.84%14K | -52.75%43K | -52.31%31K | -88.67%91K | --65K | --803K | ---- | ---- | ---- | ---- |
Financing cost | -22.81%-13.94M | -55.13%-30.28M | -35.89%-11.35M | -0.80%-19.52M | 23.04%-8.35M | 26.40%-19.36M | 26.52%-10.85M | 0.61%-26.31M | 6.24%-14.77M | 34.15%-26.47M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | -115.04%-782.81K | 2,514.48%3.96M | --5.21M | ---163.99K |
Earning before tax | -109.03%-5.92M | 98.44%-15.18M | 171.45%65.57M | -104.47%-975M | -1,867.11%-91.76M | -20.56%-476.84M | 115.73%5.19M | -896.25%-395.52M | -162.31%-33.01M | -66.67%49.67M |
Tax | -96.67%-2.6M | ---1.32M | ---1.32M | ---- | ---- | -258.79%-101.27M | -109.76%-1.13M | 1,992.89%63.78M | 14,896.69%11.54M | 81.59%-3.37M |
After-tax profit from continuing operations | -113.26%-8.52M | 98.31%-16.5M | 170.01%64.24M | -68.65%-975M | -2,356.70%-91.76M | -74.26%-578.11M | 118.94%4.07M | -816.45%-331.75M | -140.58%-21.47M | -64.58%46.3M |
Earning after tax | -113.26%-8.52M | 98.31%-16.5M | 170.01%64.24M | -68.65%-975M | -2,356.70%-91.76M | -74.26%-578.11M | 118.94%4.07M | -816.45%-331.75M | -140.58%-21.47M | -64.58%46.3M |
Profit attributable to shareholders | -113.26%-8.52M | 98.31%-16.5M | 170.01%64.24M | -68.65%-975M | -2,356.70%-91.76M | -74.26%-578.11M | 118.94%4.07M | -816.45%-331.75M | -140.58%-21.47M | -64.58%46.3M |
Basic earnings per share | -114.81%-0.04 | 98.27%-0.07 | 171.05%0.27 | -68.75%-4.05 | -2,000.00%-0.38 | -73.91%-2.4 | 122.22%0.02 | -790.00%-1.38 | -137.61%-0.09 | -67.58%0.2 |
Diluted earnings per share | -114.81%-0.04 | 98.27%-0.07 | 171.05%0.27 | -68.75%-4.05 | -2,000.00%-0.38 | -73.91%-2.4 | 122.22%0.02 | -790.00%-1.38 | -137.61%-0.09 | -67.58%0.2 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data